Summary:
An international umbrella review led by the European Academy of Neurology (EAN) in partnership with the Medical University of Vienna (MedUni Vienna) finds that chronic insomnia is linked to substantially higher risks for several serious health outcomes. The pooled evidence shows a 26% increased risk of stroke and a 28% rise in hospital admissions among people with persistent insomnia. The review also highlights consistent associations between long-term sleep disruption and elevated risks of Alzheimer’s disease, major depression, and suicidal behavior.
Key Facts:
- Elevated Stroke Risk: A combined analysis of studies covering more than 1.3 million participants found that people with insomnia had a 26% higher risk of experiencing a stroke.
- Increased Hospitalizations: Individuals with chronic insomnia were 28% more likely to be admitted to hospital compared with those who sleep well.
- Warning Sign for Brain and Mental Health: Although causation was not established, the evidence links insomnia with higher risks of dementia—particularly Alzheimer’s disease—as well as clinical depression and suicidal behavior.
Source: Medical University of Vienna / European Academy of Neurology
Insomnia is more than a nightly nuisance. While it commonly undermines sleep quality, cognitive sharpness and daytime functioning, this comprehensive review positions persistent sleep disturbance as an important clinical signal for broader vascular, neurological and psychiatric risks.
Published in Sleep Medicine Reviews, this umbrella systematic review examined existing epidemiological evidence across seven major endpoints: stroke, dementia, depression, suicidal behavior, mortality, workplace accidents and hospital admissions. Where the evidence base was incomplete, the authors supplemented their synthesis by performing new meta-analyses focused on stroke, hospitalizations and occupational injuries to produce more precise quantitative estimates.
Concrete Connections to Stroke and Hospital Admissions
For stroke, the review identified nine studies that together involved more than 1.3 million participants; six of these studies were included in a pooled meta-analysis. That analysis produced an estimated hazard ratio of 1.26, indicating a 26% higher stroke risk associated with insomnia compared with non-insomnia controls.
A separate meta-analysis of five studies addressing healthcare utilization found that people with chronic insomnia had a 28% higher odds of being hospitalized for any reason than those without insomnia. These findings suggest insomnia is associated not only with specific neurological outcomes but also with broader, clinically relevant increases in acute healthcare needs.
Beyond these acute outcomes, the umbrella review integrated multiple prior systematic reviews linking insomnia to chronic brain and mental health conditions. The most consistent patterns were observed for dementia—particularly Alzheimer’s disease—major depressive disorder and suicidal behavior. However, the degree of statistical consistency and strength of association varied across outcomes and between individual studies.
“Sleep should be part of the discussion on brain health at every stage of life,” said study co-author Stefan Seidel, M.D., a neurologist and sleep specialist at MedUni Vienna and medical director of the Pirawarth Clinic. “We should raise awareness of insomnia and its treatment and ensure that sleep is also taken into account in health promotion programmes in communities, schools and the workplace.”
Interpreting the Findings: Correlation, Not Proven Causation
The authors stress that these results represent strong observational associations rather than proven cause-and-effect relationships. Variability in how insomnia was defined across original studies, differences in study populations, and potential confounding factors—such as baseline cardiometabolic health or use of sleep medications—mean that individual risk estimates should be interpreted with caution.
Nevertheless, the researchers conclude that chronic insomnia should no longer be viewed as a benign or isolated symptom. Instead, persistent sleep problems warrant recognition as an early clinical red flag that may signal declining systemic and cognitive health and merit timely assessment and management.
Public Health and Clinical Implications
From a public health perspective, these findings support integrating sleep assessment into preventive health programs and routine clinical care. Clinicians should consider evaluating sleep quality when assessing patients’ vascular risk profiles and mental health, and policymakers may wish to include sleep promotion in community, school and workplace wellness initiatives.
Effective identification and treatment of insomnia—using evidence-based behavioral and medical approaches where appropriate—could help reduce the burden of associated health problems. The review highlights the need for further research to clarify mechanisms linking poor sleep with vascular and neuropsychiatric outcomes and to determine whether improving sleep reduces these risks.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- Journal paper reviewed in full.
- Additional context added by staff.
About this Neurology Research:
- Media Contact: Karin Kirschbichler
- Source: Medical University of Vienna
- Image Credit: Image credited to Neuroscience News
- Original Research (Open Access): Sleep Medicine Reviews (Sept 22, 2026). “Insomnia as a risk factor for brain, mental and general health consequences: an umbrella systematic review.” Authors: Luca Vignatelli, Maurizio A. Leone, Elisabetta Pupillo, Stefan Seidel, Ulf Kallweit, Natalia Colorado Prieto, Maria Lolich, Marina Tüzün, and Claudio L. A. Bassetti.
- DOI: 10.1016/j.smrv.2026.102372
Abstract
Insomnia as a risk factor for brain, mental and general health consequences: an umbrella systematic review
Sleep quality is an important determinant of overall health, and insomnia may represent a risk factor for adverse brain outcomes. To assess the current evidence, the authors searched MEDLINE and EMBASE (last search August 2025) for systematic reviews with meta-analysis that examined insomnia as a predictor of dementia, stroke, depression, suicide, death, occupational injuries and hospitalization.
Sixteen systematic reviews with meta-analyses (SMRAs) were included. Because published SMRAs were not available for stroke, occupational injuries and hospitalization, the investigators performed three additional original systematic reviews and meta-analyses for those endpoints. SMRAs consistently identified insomnia as a predictor of dementia, depression and suicide, while no consistent association was found with all-cause mortality.
The two original meta-analyses conducted by the team found that insomnia predicts stroke (9 studies, 1,343,164 participants; HR = 1.26, 95% CI 1.05–1.53) and hospitalization for any cause (5 studies, 517,620 participants; OR = 1.28, 95% CI 1.14–1.43). For occupational injuries, only two studies were available (143,942 participants), and results were not combinable in a meta-analysis.
Although some data linked insomnia to unintentional fatal injuries and commuting injuries, available evidence was insufficient to draw definitive conclusions for these outcomes. Overall, this work clarifies and strengthens the evidence that chronic insomnia is associated with key descriptors of brain health and with broader indicators of general health risk.